Prognostic factors following complete resection of non-superior sulcus lung cancer invading the chest wall.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 04 09 2019
revised: 07 01 2020
accepted: 08 01 2020
pubmed: 11 2 2020
medline: 22 6 2021
entrez: 11 2 2020
Statut: ppublish

Résumé

Locally advanced non-small-cell lung cancer (NSCLC) with chest wall invasion carries a high risk of recurrence and portends poor survival (30-40% and 20-50%, respectively). No studies have identified prognostic factors in patients who underwent R0 resection for non-superior sulcus NSCLC. A retrospective review was conducted for all chest wall resections for NSCLC from 2004 to 2018. Patients with superior sulcus tumours, partial (<1 rib) or incomplete (R1/R2) resection or distant metastasis were excluded. Disease-free survival (DFS) and overall survival (OS) were estimated using the Kaplan-Meier method. Cox proportional hazards modelling was used to determine factors associated with DFS and OS. A total of 100 patients met inclusion criteria. Seventy-three (73%) patients underwent induction therapy, and all but 12 (16%) patients experienced a partial radiological response. A median of 3 ribs was resected (range 1-7), and 67 (67%) patients underwent chest wall reconstruction. The 5-year DFS and OS were 36% and 45%, respectively. Pathological N2 status [hazard ratio (HR) 3.12, confidence interval (CI) 1.56-6.25; P = 0.001], intraoperative blood transfusion (HR 2.24, CI 1.28-3.92; P = 0.005) and preoperative forced vital capacity (per % forced vital capacity, HR 0.97, CI 0.96-0.99; P = 0.013) were associated with DFS. Increasing pathological stage, lack of radiological response to induction therapy (HR 7.35, CI 2.35-22.99; P = 0.001) and cardiovascular comorbidity (HR 2.43, CI 1.36-4.36; P = 0.003) were associated with OS. We demonstrate that blood transfusion and forced vital capacity are associated with DFS after R0 resection for non-superior sulcus NSCLC, while radiological response to induction therapy greatly influences OS. We confirm that pathological nodal status and pathological stage are reproducible determinants of DFS and OS, respectively.

Identifiants

pubmed: 32040170
pii: 5732798
doi: 10.1093/ejcts/ezaa027
pmc: PMC7305839
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-85

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Références

Chest. 2003 Jul;124(1):102-7
pubmed: 12853510
J Clin Oncol. 2007 Jan 20;25(3):313-8
pubmed: 17235046
Ann Thorac Surg. 2014 May;97(5):1827-37
pubmed: 24674755
Surg Clin North Am. 1987 Oct;67(5):959-64
pubmed: 3629432
J Clin Oncol. 1991 Jan;9(1):191-2
pubmed: 1985169
J Thorac Cardiovasc Surg. 2019 Jun;157(6):2469-2477.e10
pubmed: 30902468
Semin Plast Surg. 2011 Feb;25(1):16-24
pubmed: 22294939
Thorac Surg Clin. 2017 May;27(2):195-199
pubmed: 28363374
J Thorac Oncol. 2011 Sep;6(9):1530-6
pubmed: 21792074
Lung Cancer. 2017 Apr;106:37-41
pubmed: 28285692
J Natl Cancer Inst. 2000 Feb 2;92(3):205-16
pubmed: 10655437
Elife. 2018 Sep 04;7:
pubmed: 30178746
Lung Cancer. 2017 Feb;104:79-84
pubmed: 28213006
Ann Thorac Surg. 2005 Dec;80(6):2032-40
pubmed: 16305839
Ann Thorac Surg. 1999 Jul;68(1):188-93
pubmed: 10421139
J Thorac Cardiovasc Surg. 2001 Apr;121(4):649-56
pubmed: 11279404
J Clin Oncol. 2008 Feb 1;26(4):644-9
pubmed: 18235125
Tumori. 2019 Aug;105(4):331-337
pubmed: 30905273
Eur J Cardiothorac Surg. 2000 Nov;18(5):513-8
pubmed: 11053809
Thorac Surg Clin. 2010 Nov;20(4):519-27
pubmed: 20974435
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542

Auteurs

Gregory D Jones (GD)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Raul Caso (R)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Jae Seong No (JS)

Weill Cornell Medical College, New York, NY, USA.

Kay See Tan (KS)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Joseph Dycoco (J)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Manjit S Bains (MS)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Valerie W Rusch (VW)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

James Huang (J)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

James M Isbell (JM)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Daniela Molena (D)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Bernard J Park (BJ)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

David R Jones (DR)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Gaetano Rocco (G)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH